115 related articles for article (PubMed ID: 15790543)
1. Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
Pusztai L; Rouzier R; Wagner P; Symmans WF
Drug Resist Updat; 2004 Dec; 7(6):325-31. PubMed ID: 15790543
[TBL] [Abstract][Full Text] [Related]
2. Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?
Bonnefoi H; Underhill C; Iggo R; Cameron D
Eur J Cancer; 2009 Jul; 45(10):1733-43. PubMed ID: 19477634
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Marsh S; Liu G
Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.
Andre F; Pusztai L
Nat Clin Pract Oncol; 2006 Nov; 3(11):621-32. PubMed ID: 17080180
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer chemotherapy.
McArthur HL; Hudis CA
Cancer J; 2007; 13(3):141-7. PubMed ID: 17620762
[TBL] [Abstract][Full Text] [Related]
6. Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer.
Shimizu C; Ando M; Kouno T; Katsumata N; Fujiwara Y
Jpn J Clin Oncol; 2007 Jan; 37(1):1-8. PubMed ID: 17202251
[TBL] [Abstract][Full Text] [Related]
7. Development of the 21-gene assay and its application in clinical practice and clinical trials.
Sparano JA; Paik S
J Clin Oncol; 2008 Feb; 26(5):721-8. PubMed ID: 18258979
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
Nishiyama M; Eguchi H
Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemotherapy treatment of breast cancer--a review.
Buzdar AU
Cancer; 2007 Dec; 110(11):2394-407. PubMed ID: 17941030
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
Tewari M; Krishnamurthy A; Shukla HS
Surg Oncol; 2008 Dec; 17(4):301-11. PubMed ID: 18467090
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
13. Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?
Biganzoli L; Claudino WM; Pestrin M; Pozzessere D; Di Leo A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):1-8. PubMed ID: 17317203
[TBL] [Abstract][Full Text] [Related]
14. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
15. [Breast cancer: nomograms to predict pathologic response after preoperative chemotherapy].
Rouzier R; Coutant C; Incitti R; Natowicz R; Chahine G; Uzan S; Atallah D
J Med Liban; 2009; 57(2):89-92. PubMed ID: 19623884
[TBL] [Abstract][Full Text] [Related]
16. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
Jaremko M; Justenhoven C; Schroth W; Abraham BK; Fritz P; Vollmert C; Illig T; Simon W; Schwab M; Brauch H
Pharmacogenet Genomics; 2007 Jul; 17(7):529-38. PubMed ID: 17558308
[TBL] [Abstract][Full Text] [Related]
18. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
19. Current status of dose-dense chemotherapy for breast cancer.
Seidman AD
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
[TBL] [Abstract][Full Text] [Related]
20. Personalized systemic treatment for breast cancer patients: is it a reality?
Shimizu C; Fujiwara Y
Breast Cancer; 2008; 15(2):141-4. PubMed ID: 18274835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
